Annual Cash & Cash Equivalents:
$120.26M+$10.29M(+9.36%)Summary
- As of today, KYMR annual cash & cash equivalents is $120.26 million, with the most recent change of +$10.29 million (+9.36%) on December 31, 2024.
- During the last 3 years, KYMR annual cash & cash equivalents has risen by +$72.28 million (+150.66%).
- KYMR annual cash & cash equivalents is now at all-time high.
Performance
KYMR Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$505.68M-$159.76M(-24.01%)Summary
- As of today, KYMR quarterly cash & cash equivalents is $505.68 million, with the most recent change of -$159.76 million (-24.01%) on September 30, 2025.
- Over the past year, KYMR quarterly cash & cash equivalents has dropped by -$44.29 million (-8.05%).
- KYMR quarterly cash & cash equivalents is now -24.01% below its all-time high of $665.45 million, reached on June 30, 2025.
Performance
KYMR Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KYMR Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +9.4% | -8.1% |
| 3Y3 Years | +150.7% | +4.9% |
| 5Y5 Years | +58.2% | +72.1% |
KYMR Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +150.7% | -24.0% | +41.3% |
| 5Y | 5-Year | at high | +287.9% | -24.0% | +72.1% |
| All-Time | All-Time | at high | +287.9% | -24.0% | +449.9% |
KYMR Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $505.68M(-24.0%) |
| Jun 2025 | - | $665.45M(+43.7%) |
| Mar 2025 | - | $463.15M(-5.2%) |
| Dec 2024 | $120.26M(+9.4%) | $488.74M(-11.1%) |
| Sep 2024 | - | $549.97M(+7.8%) |
| Jun 2024 | - | $509.95M(-2.0%) |
| Mar 2024 | - | $520.54M(+38.9%) |
| Dec 2023 | $109.97M(+60.8%) | $374.88M(+4.8%) |
| Sep 2023 | - | $357.82M(-2.7%) |
| Jun 2023 | - | $367.57M(-7.4%) |
| Mar 2023 | - | $396.88M(-2.5%) |
| Dec 2022 | $68.39M | $407.17M(-15.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $481.91M(+22.8%) |
| Jun 2022 | - | $392.31M(-6.8%) |
| Mar 2022 | - | $420.81M(-4.9%) |
| Dec 2021 | $47.98M(+54.7%) | $442.42M(-17.5%) |
| Sep 2021 | - | $536.39M(+49.4%) |
| Jun 2021 | - | $359.11M(+7.7%) |
| Mar 2021 | - | $333.54M(+12.6%) |
| Dec 2020 | $31.00M(-59.2%) | $296.20M(+0.8%) |
| Sep 2020 | - | $293.84M(+88.4%) |
| Jun 2020 | - | $155.97M(+69.6%) |
| Dec 2019 | $76.02M(+84.2%) | $91.96M |
| Dec 2018 | $41.26M | - |
FAQ
- What is Kymera Therapeutics, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Kymera Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Kymera Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of KYMR is $120.26M
What is the all-time high annual cash & cash equivalents for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high annual cash & cash equivalents is $120.26M
What is Kymera Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, KYMR annual cash & cash equivalents has changed by +$10.29M (+9.36%)
What is Kymera Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of KYMR is $505.68M
What is the all-time high quarterly cash & cash equivalents for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $665.45M
What is Kymera Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, KYMR quarterly cash & cash equivalents has changed by -$44.29M (-8.05%)